Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Published:2016-11 Issue:11 Volume:17 Page:1509-1520
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sun Ying,Li Wen-Fei,Chen Nian-Yong,Zhang Ning,Hu Guo-Qing,Xie Fang-Yun,Sun Yan,Chen Xiao-Zhong,Li Jin-Gao,Zhu Xiao-Dong,Hu Chao-Su,Xu Xiang-Ying,Chen Yuan-Yuan,Hu Wei-Han,Guo Ling,Mo Hao-Yuan,Chen Lei,Mao Yan-Ping,Sun Rui,Ai Ping,Liang Shao-Bo,Long Guo-Xian,Zheng Bao-Min,Feng Xing-Lai,Gong Xiao-Chang,Li Ling,Shen Chun-Ying,Xu Jian-Yu,Guo Ying,Chen Yu-Ming,Zhang Fan,Lin Li,Tang Ling-Long,Liu Meng-Zhong,Ma Jun

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging;Mao;Int J Radiat Oncol Biol Phys,2009

3. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?;Lai;Int J Radiat Oncol Biol Phys,2011

4. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial;Chen;Lancet Oncol,2012

Cited by 672 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and application of nasopharyngeal carcinoma-specific big data platform based on electronic health records;American Journal of Otolaryngology;2024-05

2. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma;Cell Death & Disease;2024-02-06

3. Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial;Nature Communications;2024-02-03

4. Evaluation of erastin synergized cisplatin anti-nasopharyngeal carcinoma effect with a glutathione-activated near-infrared fluorescent probe;Chinese Chemical Letters;2024-02

5. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02